SOX2, a master regulator of embryonic and induced pluripotent stem cells, promotes self-renewal and drug resistance, fuels tumor initiation, and contributes to tumor aggressiveness in CRC 14. This evidence concerns the gene SOX2 and colorectal carcinoma.